{"id":"W4407700779","doi":"10.1200/jco.2025.43.5_suppl.151","title":"Darolutamide plus ADT in patients with metastatic hormone-sensitive prostate cancer (mHSPC) by disease volume: Subgroup analysis of the phase 3 ARANOTE trial.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bayer (Canada); Université de Montréal","funders":"Bayer","keywords":"Medicine; Prostate cancer; Oncology; Subgroup analysis; Internal medicine; Docetaxel; Disease; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003906326,0.001369275,0.003564477,0.0006502415,0.0002162505,0.001034955,0.0006818869,0.0009063796,0.003415781],"category_scores_gemma":[0.003161891,0.0003969714,0.008083997,0.0007912642,0.0003333611,0.000558698,0.0005665841,0.001387825,0.0002662384],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005422459,"about_ca_system_score_gemma":0.000815961,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008209438,"about_ca_topic_score_gemma":0.003328571,"domain_scores_codex":[0.9981703,0.001139662,0.0002123589,0.0001936951,0.0001286842,0.000155356],"domain_scores_gemma":[0.9988028,0.0005742566,0.0003038489,0.0001446075,0.00004558943,0.0001289471],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8932166,0.0006860197,0.01620077,0.003726871,0.05400649,0.0002741303,0.00009424004,0.001280261,0.003507724,0.0001979421,0.002117038,0.02469189],"study_design_scores_gemma":[0.7053196,0.05891172,0.09811644,0.0006238055,0.121436,0.0007539439,0.000281032,0.004556305,0.001814793,0.001871317,0.006163264,0.0001517225],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9447665,0.04438534,0.001214392,0.0007000047,0.0004682223,0.00157874,0.004527018,0.00009228174,0.002267594],"genre_scores_gemma":[0.9907419,0.004095206,0.0006157907,0.0005048363,0.0002422428,0.000929344,0.001980106,0.000019824,0.0008708315],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003906326,"threshold_uncertainty_score":0.02065885,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05157142380122449,"score_gpt":0.4635281773739748,"score_spread":0.4119567535727503,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}